Seramune Oral

This page contains information on Seramune Oral for veterinary use.
The information provided typically includes the following:

Seramune Oral Indications
Warnings and cautions for Seramune Oral
Direction and dosage information for Seramune Oral

Seramune Oral

This treatment applies to the following species:

Horses

Company: Sera

equine IgG

bottle contains one dose of 300mL

administer orally in two even amounts 1-2 hours apart, within first 12 hours of life

● protect from sunlight

● store refrigerated at 2 - 8° C/35 - 46° F; do not freeze

● once opened, use entire contents as directed above.

Seramune Oral Indications

for the treatment of failure of passive transfer in neonatal foals

do not mix with other products, except as specified on the label

with any serum product, adverse reactions may occur; in case of reactions, stop treatment and administer epinephrine

use of serum and plasma products has been associated with hepatitis (Theiler’s Disease)

VLN/PCN 328/3607.01

300mL

sera^®, po box 15866, shawnee mission, kansas 66285-5866 usa

913-541-1307

CPN: 1498001.4

SERA, INC.
P.O. BOX 15866, SHAWNEE MISSION, KS, 66285-5866

Telephone:		913-541-1307
Customer Service:		adamforeman@seramune.com
Order Desk:		adamforeman@seramune.com
Technical Service:		nicolegreen@seramune.com
Website:		www.seramune.com
Email:		info@seramune.com

THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.